More good news came out of Israel on Saturday when the country's health ministry released another round of data on the Pfizer-BioNTech COVID-19 vaccine, further affirming its effectiveness.

13 and compare the vaccinated and unvaccinated populations, show that the jab has been nearly 96 percent effective at preventing symptomatic COVID-19 infections two weeks after individuals receive their second dose.

When it comes to preventing severe infections, hospitalizations, and deaths from the coronavirus, the figure jumps to an efficacy rate around 99 percent.

Israel’s Ministry of Health says benefits of #PfizerVaccine 14 days after 2jab are:.

• 95.8% preventing illness cases.

• 98.0% preventing fever and/or respiratory symptoms.

• 98.9% preventing hospitalization.

• 99.2% preventing severe illness.

• 98.9% preventing death.

Israel has emerged as the world's clearest case study for determining whether the Pfizer vaccine works, since the country has the highest vaccination rate in the world.

The risk of illness from COVID-19 dropped 95.8% among people who received both shots of Pfizer's vaccine, Israel's Health Ministry said on Saturday.

The vaccine was also 98% effective in preventing fever or breathing problems and 98.9% effective in preventing hospitalizations and death, the ministry said.

Russia has registered the first case of a strain of bird flu virus named A(H5N8) being passed to humans from birds and has reported the matter to the World Health Organization (WHO), Anna Popova, head of consumer health watchdog Rospotrebnadzor, said on Saturday.

Drug company says vaccine doesn't need deep-freeze storage, which could ease distribution, as Israeli study shows 1st dose alone highly effective.

It’s presence and freedom in presence.” Read original story Jim Carrey Retires From Political Cartooning With ‘Orange Julius Caesar’ Out of Office At TheWrap